Cara Therapeutics
Latest round
- Series D
Last raised
- Jul 2010
Total raised
- $51M
Investors
- 9
About Cara Therapeutics
Cara Therapeutics Inc.Founded in 2004 in Shelton, US, Cara Therapeutics Inc. focuses on developing novel treatments for pain and itch management.Cara Therapeutics specializes in creating therapeutics that target the body's opioid receptors to alleviate various types of pain and itch.Cara Therapeutics aims to expand its product offerings by introducing new therapies targeting additional pain and itch conditions, with ongoing development efforts slated for the coming years. The company is also looking to enter new geographic markets, focusing on Europe and certain regions of Asia by 2025.
Who invested in Cara Therapeutics
9 investors across 4 rounds
See all investors in Cara Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cara Therapeutics
Who invested in Cara Therapeutics?
Cara Therapeutics has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cara Therapeutics raised?
Cara Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Cara Therapeutics last raise money?
Cara Therapeutics's most recent round on record is a Series D, in Jul 2010.
What does Cara Therapeutics do?
Cara Therapeutics is a biotechnology company.
Where is Cara Therapeutics headquartered?
Cara Therapeutics is headquartered in Stamford, US.
Which VCs invest in companies like Cara Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cara Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Cara Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.